Ratings by Rodman & Renshaw (Brandon Folkes)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/25/2025 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2025 | Adial Pharmaceuticals Inc | ADIL | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2025 | Cardiol Therapeutics | CRDL | New Coverage | Buy (N/A) |
1.29 (1.18) |
-8.53% | Details | |
| 1/28/2025 | Indivior | INDV | New Coverage | Buy (N/A) |
12.02 (40.53) |
237.19% | Details | |
| 1/28/2025 | Rein Therapeutics | RNTX | New Coverage | Buy (N/A) |
2.10 (0.79) |
-62.38% | Details | |
| 1/28/2025 | PolyPid Ltd. | PYPD | New Coverage | Buy (N/A) |
3.15 (3.90) |
23.81% | Details | |
| 1/28/2025 | Talphera | TLPH | New Coverage | Buy (N/A) |
0.72 (1.35) |
87.5% | Details | |
| 11/14/2024 | Rockwell Medical Technologies | RMTI | New Coverage | Buy (N/A) |
2.63 (6.63) |
152.09% | Details | |
| 11/14/2024 | Eupraxia Pharmaceuticals | EPRX | New Coverage | Buy (N/A) |
2.84 (5.81) |
104.58% | Details | |
| 11/14/2024 | Achieve Life Sciences | ACHV | New Coverage | Buy (N/A) |
4.53 (6.10) |
34.66% | Details | |
| 11/14/2024 | Adial Pharmaceuticals Inc | ADIL | New Coverage | Buy (N/A) |
0.99 (2.78) |
180.81% | Details | |
| 11/14/2024 | Omeros Corp. | OMER | New Coverage | Buy (N/A) |
4.19 (9.79) |
133.65% | Details | |
| 8/26/2024 | CorMedix | CRMD | New Coverage | Buy (N/A) |
5.65 (7.87) |
39.29% | Details | |
| 6/13/2024 | Trevi Therapeutics | TRVI | New Coverage | Buy (N/A) |
2.60 (17.54) |
574.62% | Details | |
| 6/13/2024 | Scilex Holding Co. | SCLX | New Coverage | Buy (N/A) |
1.33 (6.84) |
414.29% | Details | |
| 6/13/2024 | Heron Therapeutics | HRTX | New Coverage | Buy (N/A) |
3.64 (0.46) |
-87.36% | Details | |
| 6/13/2024 | Rani Therapeutics Holdsing s | RANI | New Coverage | Buy (N/A) |
4.01 (0.85) |
-78.8% | Details | |
| 6/13/2024 | MannKind | MNKD | New Coverage | Buy (N/A) |
4.65 (4.13) |
-11.18% | Details |
